Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome

Autor: R, Das Chakraborty, D, Chakraborty, A J, Bernal, K, Schoch, T D, Howard, E H, Ip, S R, Hooper, M S, Keshavan, R L, Jirtle, V, Shashi
Rok vydání: 2012
Předmět:
Male
Chromosomes
Human
Pair 22

Gene Expression
Epigenesis
Genetic

0302 clinical medicine
Reference Values
DiGeorge syndrome
Imprinting (psychology)
Child
Genetics
0303 health sciences
Extracellular Matrix Proteins
Psychopathology
Nuclear Proteins
Microdeletion syndrome
Anxiety Disorders
Psychiatry and Mental health
Anxiety
DGCR6L
Female
Schizophrenic Psychology
Original Article
medicine.symptom
Chromosome Deletion
Psychology
Algorithms
Adolescent
Genotype
Polymorphism
Single Nucleotide

03 medical and health sciences
Cellular and Molecular Neuroscience
Genomic Imprinting
22q11DS syndrome
DGCR6
medicine
DiGeorge Syndrome
Humans
Abnormalities
Multiple

Epigenetics
Biological Psychiatry
030304 developmental biology
epigenetics
Computational Biology
Proteins
Epigenome
medicine.disease
schizophrenia
Behavioral medicine
Genomic imprinting
030217 neurology & neurosurgery
Zdroj: Translational Psychiatry
ISSN: 2158-3188
Popis: Chromosome 22q11.2 deletion syndrome (22q11DS) is the most common microdeletion syndrome in humans. It is typified by highly variable symptoms, which might be explained by epigenetic regulation of genes in the interval. Using computational algorithms, our laboratory previously predicted that DiGeorge critical region 6 (DGCR6), which lies within the deletion interval, is imprinted in humans. Expression and epigenetic regulation of this gene have not, however, been examined in 22q11DS subjects. The purpose of this study was to determine if the expression levels of DGCR6 and its duplicate copy DGCR6L in 22q11DS subjects are associated with the parent-of-origin of the deletion and childhood psychopathologies. Our investigation showed no evidence of parent-of-origin-related differences in expression of both DGCR6 and DGCR6L. However, we found that the variability in DGCR6 expression was significantly greater in 22q11DS children than in age and gender-matched control individuals. Children with 22q11DS who had anxiety disorders had significantly lower DGCR6 expression, especially in subjects with the deletion on the maternal chromosome, despite the lack of imprinting. Our findings indicate that epigenetic mechanisms other than imprinting contribute to the dysregulation of these genes and the associated childhood psychopathologies observed in individuals with 22q11DS. Further studies are now needed to test the usefulness of DGCR6 and DGCR6L expression and alterations in the epigenome at these loci in predicting childhood anxiety and associated adult-onset pathologies in 22q11DS subjects.
Databáze: OpenAIRE